NCT03060941 (PACES) is a NA clinical trial of Physical activity education in Physical Activity, sponsored by University of Texas Southwestern Medical Center.

Who is sponsoring NCT03060941?

NCT03060941 is sponsored by University of Texas Southwestern Medical Center.

What drugs are being tested in NCT03060941?

Interventions in NCT03060941: Physical activity education, Facility access, Supervised exercise sessions, Self-monitoring (Fitbit), Active living counseling.

What condition does NCT03060941 study?

NCT03060941 studies Physical Activity, Breast Cancer.

Is NCT03060941 still recruiting?

NCT03060941 is currently completed. Last updated 26 January 2021.

Last reviewed 2021-01-26 · How we verify

NCT03060941: PACES

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Promoting Activity in Cancer Survivors

Completed NA Last updated 26 January 2021

What this trial tests

NA trial testing Physical activity education in Physical Activity in 355 participants. Completed in 28 February 2020.

Timeline

4 December 2017

Primary endpoint
28 February 2020

28 February 2020

Quick facts

Lead sponsor	University of Texas Southwestern Medical Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	355
Start date	4 December 2017
Primary completion	28 February 2020
Estimated completion	28 February 2020
Sites	1 location across United States

Drugs / interventions tested

Physical activity education
Facility access
Supervised exercise sessions
Self-monitoring (Fitbit)
Active living counseling

Conditions studied

Physical Activity — all drugs for Physical Activity →
Breast Cancer — all drugs for Breast Cancer →

Sponsor

University of Texas Southwestern Medical Center

Who can join

18 and older, female only, with Physical Activity or Breast Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A randomized multi-component physical activity intervention for breast cancer survivors.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Considering depression as a secondary outcome in the optimization of physical activity interventions for breast cancer survivors in the PACES trial: a factorial randomized controlled trial.
Rethorst CD, Carmody TJ, Argenbright KE, Mayes TL, et al · · 2023 · cited 8× · PMID 37081460 · DOI 10.1186/s12966-023-01437-x
The Promoting Activity in Cancer Survivors (PACES) trial: a multiphase optimization of strategy approach to increasing physical activity in breast cancer survivors.
Rethorst CD, Hamann HA, Carmody TJ, Sharp KJ, et al · · 2018 · cited 8× · PMID 30021554 · DOI 10.1186/s12885-018-4662-5

Verify or expand the search:

Other trials of Physical activity education

Trials testing the same drug.

NCT06820021 — Strength-based Tailored-Exercise Program at Home for Geriatric Patients · NA · recruiting
NCT02990754 — Fearless Physical Activity: Getting and Keeping Ontarians With Congenital Heart Disease Active · NA · completed

Other recruiting trials for Physical Activity

Currently open trials in the same condition.

NCT07466797 — The eHealth Integrated Maternal Physical Activity Programme in Prenatal Care Trial (E-IMPACT) · NA · recruiting
NCT07466914 — Constipation in Children With Cerebral Palsy · active not recruiting
NCT07290309 — Survivors Uniting for Remote Guided Exercise · NA · recruiting
NCT07415460 — Evaluating the Impact of SKY Breath Meditation on Stress, Well-being, and Connection in College Students · NA · recruiting
NCT07585409 — Physical Activity in Persons With Parkinson's Disease · recruiting

Other University of Texas Southwestern Medical Center trials

Trials by the same sponsor.

NCT03849963 — Imaging Oxidative Metabolism and Neurotransmitter Synthesis in the Human Brain · recruiting
NCT06917183 — Developing Strategies for Implementation and Use of the Operating Room Black Box (ORBB) · NA · not yet recruiting
NCT05145309 — Value of Potassium Magnesium Citrate in Preventing and Treating Hypertension in African Americans · Phase 2 · not yet recruiting
NCT06552000 — Pre-operative Tumor Treating Fields in Patients With Resectable Lung Cancer · NA · not yet recruiting
NCT07387666 — Imaging Acetadote Metabolism in Glioblastoma · EARLY_PHASE1 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03060941 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Texas Southwestern Medical Center
Last refreshed: 26 January 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03060941.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing